Lunai Bioworks, Inc. (LNAI)
1.93
-0.01
(-0.52%)
USD |
NASDAQ |
Sep 25, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 19:59
Lunai Bioworks Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 27, 2025 | 0.5378 |
| June 26, 2025 | 0.6414 |
| June 25, 2025 | 0.6572 |
| June 24, 2025 | 0.6543 |
| June 23, 2025 | 0.6765 |
| June 20, 2025 | 0.6273 |
| June 18, 2025 | 0.6309 |
| June 17, 2025 | 0.6605 |
| June 16, 2025 | 0.6353 |
| June 13, 2025 | 0.6712 |
| June 12, 2025 | 0.6974 |
| June 11, 2025 | 0.6333 |
| June 10, 2025 | 0.6991 |
| June 09, 2025 | 0.662 |
| June 06, 2025 | 0.5675 |
| June 05, 2025 | 0.5747 |
| June 04, 2025 | 0.5442 |
| June 03, 2025 | 0.5291 |
| June 02, 2025 | 0.5326 |
| May 30, 2025 | 0.569 |
| May 29, 2025 | 0.5787 |
| May 28, 2025 | 0.5782 |
| May 27, 2025 | 0.5879 |
| May 23, 2025 | 0.6004 |
| May 22, 2025 | 0.6126 |
| Date | Value |
|---|---|
| May 21, 2025 | 0.5313 |
| May 20, 2025 | 0.5332 |
| May 19, 2025 | 0.5802 |
| May 16, 2025 | 0.5916 |
| May 15, 2025 | 0.6113 |
| May 14, 2025 | 0.6063 |
| May 13, 2025 | 0.6159 |
| May 12, 2025 | 0.5938 |
| May 09, 2025 | 0.58 |
| May 08, 2025 | 0.5659 |
| May 07, 2025 | 0.5754 |
| May 06, 2025 | 0.5332 |
| May 05, 2025 | 0.5863 |
| May 02, 2025 | 0.6171 |
| May 01, 2025 | 0.5686 |
| April 30, 2025 | 0.6609 |
| April 29, 2025 | 0.6216 |
| April 28, 2025 | 0.6684 |
| April 25, 2025 | 0.6857 |
| April 24, 2025 | 0.6849 |
| April 23, 2025 | 0.6901 |
| April 22, 2025 | 0.6397 |
| April 21, 2025 | 0.738 |
| April 17, 2025 | 0.6478 |
| April 16, 2025 | 0.6614 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 19.18 |
| Anika Therapeutics, Inc. | 1.986 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.570 |
Price to Book Value Related Metrics
| PS Ratio | 252.96 |
| Price | 1.93 |
| Earnings Yield | -3.18K% |
| Market Cap | 8.630M |